Combating drug resistance in hepatocellular carcinoma: No awareness today, no action tomorrow
Authors:
Open Access
- 25 September 2023
- journal article
- research article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 167, 115561
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82204433)
- Natural Science Foundation of Shandong Province (ZR2020QH362)
- Qingdao University
This publication has 172 references indexed in Scilit:
- Randomized, Multicenter, Open-Label Study of Oxaliplatin Plus Fluorouracil/Leucovorin Versus Doxorubicin As Palliative Chemotherapy in Patients With Advanced Hepatocellular Carcinoma From AsiaJournal of Clinical Oncology, 2013
- Differential miRNA expression profiles in hepatocellular carcinoma cells and drug-resistant sublinesOncology Reports, 2012
- OV6+ tumor-initiating cells contribute to tumor progression and invasion in human hepatocellular carcinomaJournal of Hepatology, 2012
- BMP4 Administration Induces Differentiation of CD133+ Hepatic Cancer Stem Cells, Blocking Their Contributions to Hepatocellular CarcinomaCancer Research, 2012
- Targeting autophagy potentiates chemotherapy-induced apoptosis and proliferation inhibition in hepatocarcinoma cellsCancer Letters, 2012
- Lupeol targets liver tumor-initiating cells through phosphatase and tensin homolog modulationHepatology, 2010
- CD13 is a therapeutic target in human liver cancer stem cellsJournal of Clinical Investigation, 2010
- Oncostatin M Renders Epithelial Cell Adhesion Molecule–Positive Liver Cancer Stem Cells Sensitive to 5-Fluorouracil by Inducing Hepatocytic DifferentiationCancer Research, 2010
- Wnt/β-Catenin Signaling Contributes to Activation of Normal and Tumorigenic Liver Progenitor CellsCancer Research, 2008
- Riboregulator H19 induction of MDR1-associated drug resistance in human hepatocellular carcinoma cellsOncogene, 2007